CHEST 2012


   |    CHEST 2012
Check out photos from this year's conference in Atlanta, GA, which took place from October 20-25. The meeting was held at the Georgia World Congress Center, which sits between CNN headquarters and the Georgia Dome.
   |    CHEST 2012
Robert De Marco, MD, FCCP, Intensivist, Orlando Health, Dr. Phillips Hospital, says that a concern for reimbursement in the ICU is that many private physicians are becoming hospital employed. He says that convincing the hospital they need full-time critical care coverage is a difficult task even though it saves cost and cuts down length of stay and mortalities.
   |    CHEST 2012
Brian Carlin, MD, FCCP, Allegheny General Hospital, states that there are many challenges in providing pulmonary rehabilitation to patients with chronic lung diseases.
   |    CHEST 2012
Although there has been a concentrated focus on pulmonary vascular diseases at this year's CHEST conference, there have also been a number of studies released that pertain to cardiovascular events, such as congestive heart failure, atrial fibrillation, and chronic obstructive pulmonary disease. Here are some of the highlights in these areas.
   |    CHEST 2012
As one might expect, lung cancer is one of the major focuses at each CHEST conference. The following are highlights from this year's recently released abstracts and late-breaking studies.
   |    CHEST 2012
Although there have been a wide variety of disease states covered at this year's CHEST conference, much of the focus has been on those under the umbrella of pulmonary vascular disease, such as pulmonary arterial hypertension and deep vein thrombosis. Here are some of the new study highlights related to pulmonary vascular disease.
   |    CHEST 2012
Jun Chiong, MD, MPH, FACC, FCCP, Associate Professor of Medicine, Loma Linda University Medical Center, states the US healthcare system does not utilize a team-based approach.
   |    CHEST 2012
Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, says that the issue of cost is an important factor in treating patients with pulmonary arterial hypertension.
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Neutropenia Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
Upcoming Partner Events
October 24-25, 2017
San Francisco, CA